292 related articles for article (PubMed ID: 30238355)
1. Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats.
Studneva I; Palkeeva M; Veselova O; Molokoedov A; Ovchinnikov M; Sidorova M; Pisarenko O
Cardiovasc Toxicol; 2019 Apr; 19(2):136-146. PubMed ID: 30238355
[TBL] [Abstract][Full Text] [Related]
2. [Protective action of a modified fragment of galanine in rats with doxorubicin-induced heart failure].
Studneva IM; Palkeeva ME; Veselova OM; Molokoedov AS; Lubimov RO; Ovchinnikov MV; Sidorova MV; Pisarenko OI
Biomed Khim; 2019 Jan; 65(1):51-56. PubMed ID: 30816097
[TBL] [Abstract][Full Text] [Related]
3. The Mechanisms of Cardiac Protection Using a Synthetic Agonist of Galanin Receptors during Chronic Administration of Doxorubicin.
Studneva IM; Veselova OM; Bahtin AA; Konovalova GG; Lankin VZ; Pisarenko OI
Acta Naturae; 2020; 12(1):89-98. PubMed ID: 32477603
[TBL] [Abstract][Full Text] [Related]
4. [Cardiometabolic efficacy and toxicological evaluation of a pharmacological galanin receptor agonist].
Serebryakova LI; Studneva IM; Ovchinnikov MV; Veselova OM; Molokoedov AS; Arzamastsev EV; Afanasyeva EY; Terekhova OA; Sidorova MV; Pisarenko OI
Biomed Khim; 2019 Apr; 65(3):231-238. PubMed ID: 31258147
[TBL] [Abstract][Full Text] [Related]
5. Galanin receptors activation modulates myocardial metabolic and antioxidant responses to ischaemia/reperfusion stress.
Studneva I; Serebryakova L; Veselova O; Pal'keeva M; Molokoedov A; Ovchinnikov M; Konovalova G; Lankin V; Sidorova M; Pisarenko O
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1174-1182. PubMed ID: 31429479
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
[TBL] [Abstract][Full Text] [Related]
7. Galanin/GalR1-3 system: A promising therapeutic target for myocardial ischemia/reperfusion injury.
Palkeeva M; Studneva I; Molokoedov A; Serebryakova L; Veselova O; Ovchinnikov M; Sidorova M; Pisarenko O
Biomed Pharmacother; 2019 Jan; 109():1556-1562. PubMed ID: 30551408
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
Abbas NAT; Kabil SL
Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599
[TBL] [Abstract][Full Text] [Related]
9. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
Yu X; Cui L; Zhang Z; Zhao Q; Li S
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective Effect of Phenytoin on Doxorubicin-induced Cardiac Toxicity in a Rat Model.
Razmaraii N; Babaei H; Mohajjel Nayebi A; Asadnasab G; Ashrafi Helan J; Azarmi Y
J Cardiovasc Pharmacol; 2016 Mar; 67(3):237-45. PubMed ID: 26544684
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Agonist of Galanin Receptor GALR2 Reduces Heart Damage in Rats with Streptozotocin-Induced Diabetes.
Studneva IM; Veselova OM; Dobrokhotov IV; Serebryakova LI; Palkeeva ME; Molokoedov AS; Azmuko AA; Ovchinnikov MV; Sidorova MV; Pisarenko OI
Biochemistry (Mosc); 2022 Apr; 87(4):346-355. PubMed ID: 35527373
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
Ikeda Y; Aihara K; Akaike M; Sato T; Ishikawa K; Ise T; Yagi S; Iwase T; Ueda Y; Yoshida S; Azuma H; Walsh K; Tamaki T; Kato S; Matsumoto T
Mol Endocrinol; 2010 Jul; 24(7):1338-48. PubMed ID: 20501642
[TBL] [Abstract][Full Text] [Related]
15. Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model.
Ahmad S; Panda BP; Kohli K; Fahim M; Dubey K
Pharm Biol; 2017 Dec; 55(1):1295-1303. PubMed ID: 28274156
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.
Chen CT; Wang ZH; Hsu CC; Lin HH; Chen JH
Nutrients; 2015 Jun; 7(6):4938-54. PubMed ID: 26091236
[TBL] [Abstract][Full Text] [Related]
17. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
18. Effects of Melatonin and Adrenomedullin in Reducing the Cardiotoxic Effects of Doxorubicin in Rats.
Durdagi G; Pehlivan DY; Oyar EO; Bahceci SA; Ozbek M
Cardiovasc Toxicol; 2021 May; 21(5):354-364. PubMed ID: 33389601
[TBL] [Abstract][Full Text] [Related]
19. Xinshuitong Capsule extract attenuates doxorubicin-induced myocardial edema via regulation of cardiac aquaporins in the chronic heart failure rats.
Tan C; Zeng J; Wu G; Zheng L; Huang M; Huang X
Biomed Pharmacother; 2021 Dec; 144():112261. PubMed ID: 34628163
[TBL] [Abstract][Full Text] [Related]
20. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
